Clinical Trials Logo
  1. Home
  2. Nicotine Use Disorder
  3. NCT05994209

Testing the Feasibility and Acceptability of Social Media and Digital Therapeutics to Decrease Vaping Behaviors

Nicotine Use Disorder Clinical Trial

Official title:
Testing the Feasibility and Acceptability of Social Media and Digital Therapeutics to Decrease Vaping Behaviors

Clinical Trial Summary

Use of vaping products (e.g., electronic nicotine delivery systems, e-cigarettes) has been increasing rapidly, particularly among teens and young adults. With limited information on the long-term effects of vaping products, health information about vaping has been somewhat unclear in regards to associated health risks. Teens and young adults may be reluctant to disclose their use of vaping products to parents or health providers and instead turn to social media to share and seek out information regarding vaping risks and cessation supports. Thus, our current proposal outlines the use of social media to identify teens and young adults socially networking about vaping, the use of an online chatbot screen to evaluate individual cessation support needs, and the use of a digital intervention system to support vaping cessation. The mobile intervention used in this study is based on a widely-used evidence-based mobile intervention for combustible smoking (i.e., quitSTART) and has been adapted for vaping and young adults to include an in-app chatbot to guide users to tailored content and to motivate and encourage their cessation efforts. We aim to integrate our social media recruitment and online screening approach to connect individuals with this mobile app intervention, and will conduct a randomized controlled trial to evaluate user engagement with and preliminary efficacy of the digital intervention on reducing vaping behaviors among teens and young adults.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05994209
Study type Interventional
Source Washington University School of Medicine
Contact Patricia Cavazos-Rehg, PhD
Phone 314-362-2152
Email pcavazos@wust.edu
Status Not yet recruiting
Phase Phase 1
Start date January 2024
Completion date March 2025
View Details
See also
  Status Clinical Trial Phase
Completed NCT04284813 - Families With Substance Use and Psychosis: A Pilot Study N/A
Completed NCT02511704 - Pharmacokinetics and Acute Effects of Multiple Dose of Nicotine: Electronic Cigarette and Cigarette Phase 1
Completed NCT04568395 - Acute Effects of TCIG vs ECIG in PLWH N/A
Completed NCT03338933 - Neurobiology of Alcohol and Nicotine Co-Addiction
Completed NCT03634839 - Effects of E-cigarette Flavors on Youth TCORS 2.0 Phase 1
Recruiting NCT05515354 - Smoking Cessation and Menstrual Cycle Phase Phase 4
Withdrawn NCT06259630 - Nicotine Virtual Reality Conditioned Place Preference Phase 4
Recruiting NCT06170138 - Study to Assess PK, PD, Nicotine Extraction, Palatability, Subjective Effects of Nicotine Pouches - Daily Nicotine Users N/A
Not yet recruiting NCT05932745 - Effects of Novel E-cigarette Constituents on Adults TCORS 3.0 N/A
Not yet recruiting NCT03264755 - Cortical Excitability and Role of rTMS in Nicotine Use Disorder N/A
Recruiting NCT05766254 - Identify the Optimal TMS Target to Modulate Reward Activity N/A
Completed NCT00330187 - Combined Pharmaco/Behavior Therapy in Adolescent Smokers Phase 2
Completed NCT03635333 - Effects of E-Cigarette Flavors on Adults TCORS 2.0 Phase 1
Completed NCT03438188 - Neural Basis of Eating Behavior in Abstinent Smokers N/A
Completed NCT03194958 - Helping Poor Smokers Quit N/A
Recruiting NCT04432064 - Temporal Interference Neurostimulation and Addiction N/A
Recruiting NCT05181891 - Pharmaceutically-Enhanced Reinforcement for Reduced Alcohol and Smoking Phase 2
Completed NCT05897242 - A Smartphone Application (ACT on Vaping) for Vaping Cessation in Young Adults N/A
Completed NCT03302026 - Real Time fMRI and Quitting Smoking N/A
Terminated NCT03352609 - Accelerated rTMS for the Reduction of Nicotine Craving N/A